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Abstract
For psoriasis, an idiopathic inflammatory disorder of the skin, the microbial biota has not been defined using cultivation-
independent methods. We used broad-range 16S rDNA PCR for archaea and bacteria to examine the microbiota of normal
and psoriatic skin. From 6 patients, 19 cutaneous samples (13 from diseased skin and 6 from normal skin) were obtained.
Extracted DNA was subjected to the broad range PCR, and 1,925 cloned products were compared with 2,038 products
previously reported from healthy persons. Using 98% sequence identity as a species boundary, 1,841 (95.6%) clones were
similar to known bacterial 16S rDNA, representing 6 phyla, 86 genera, or 189 species-level operational taxonomic unit
(SLOTU); 84 (4.4%) clones with ,98% identity probably represented novel species. The most abundant and diverse phylum
populating the psoriatic lesions was Firmicutes (46.2%), significantly (P,0.001) overrepresented, compared to the samples
from uninvolved skin of the patients (39.0%) and healthy persons (24.4%). In contrast, Actinobacteria, the most prevalent
and diverse phylum in normal skin samples from both healthy persons (47.6%) and the patients (47.8%), was significantly
(P,0.01) underrepresented in the psoriatic lesion samples (37.3%). Representation of Propionibacterium species were lower
in the psoriatic lesions (2.965.5%) than from normal persons (21.1618.2%; P,0.001), whereas normal skin from the
psoriatic patients showed intermediate levels (12.3621.6%). We conclude that psoriasis is associated with substantial
alteration in the composition and representation of the cutaneous bacterial biota.
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little characterized [1,2]. The major sites for our indigenous
microbiota are the oropharynx, gastrointestinal tract, vagina, and
skin [3–9]. Historically, the microbiota was defined by the isolation
of organisms in culture, but substantial proportions of bacterial and
fugal species are fastidious, resisting cultivation [2,4]. This also is
true for human skin, for which recent analyses using molecular
methods haverevealed a microbiotaof considerable diversity, much
greater than anticipated from culture-based studies [10–12]. In
addition to characterizing skin from healthy persons, use of such
approaches may be of value in understanding disease conditions.
Psoriasis, a chronic inflammatory condition of the skin, present
in about 2% of the world’s population [13], also affects
cardiovascular disease risk [14,15]. The histopathological features
of psoriasis include hyperkeratosis, hyperproliferation of keratino-
cytes, infiltration of skin by immune cells, and angiogenesis [13].
Although the causes of psoriasis are poorly understood, the disease
appears to result from a combination of genetic and environmental
factors; putative loci for genetic susceptibility to psoriasis have
been reported on the basis of genome-wide linkage studies [13].
An extensive literature also has suggested that bacteria,
including Staphylococcus aureus [16] and Streptococcus pyogenes [17],
could play a role in the induction and maintenance of psoriasis
[17–20], and group A Streptococcus (GAS) antigens or superan-
tigens have been implicated in psoriasis pathogenesis in genetically
predisposed individuals [17,21,22]. Study of the microbiota of
patients with psoriasis is thus important, and complementary to
genetic and immunological research [23,24].
Although most current knowledge of the human skin microbiota
derives from cultivation studies [5,25], culture-independent
molecular approaches have created a new basis [10–12]. One
approach, based on sequencing 16S rRNA genes conserved in all
prokaryotes, permits analysis of variable regions that allow
identification of particular species, inferences about phylogenetic
relationships with known bacteria, and construction of population
maps of the indigenous biota [1,2,6].
The aim of this study was to analyze the composition of the
microbiota in skin from patients with psoriasis to determine
PLoS ONE | www.plosone.org 1 July 2008 | Volume 3 | Issue 7 | e2719whether bacterial populations in psoriatic lesions differ from
unaffected skin, and from skin from healthy persons.
Results
Species richness and diversity
Estimations of species coverage, richness, evenness, and
diversity were calculated for the combined data set of 3,963
clones, as well as for subsets of samples defined based on sources of
specimens [healthy subjects or subjects with psoriasis] and
pathology [psoriatic lesion or uninvolved skin] (Table 1). Good’s
coverage, which accounts for both diversity and abundance, at
97% for the overall sequence set, indicated that the small subunit
rRNA gene (16S rDNA) sequences identified in these samples
represent the majority of bacterial sequences present in the human
skin samples under study. The Chao1 estimator of total species
richness was 476 (Figure 1, Panel A); however, because it did not
plateau with the current sequencing effort due to rare species, it
likely is a minimal estimate. Ecological diversity also was estimated
by Simpson’s index of diversity, the Shannon–Weaver index, and
evenness, which take into account relative abundances (Table 1).
The samples from the lesions of the patients with psoriasis contain
the most diverse taxa, with the highest values in all three of these
measures.
Phylogenetic analyses
The 16S clone libraries from the six patients with psoriasis
yielded 1,314 and 611 interpretable unique sequences for the
lesions and normal skin samples, respectively. According to the
Ribosomal Database Project II (RDP II) database, these were
grouped to 8 phyla, 94 genera, and 212 species-level operational
taxonomic units (SLOTUs) at 98% identity. In total, 1,841 cloned
sequences were similar to those of known bacterial isolates,
representing 6 phyla, 86 genera, and 189 SLOTUs. A total of 84
(4.4%) clones were ,98% identical to current GenBank entries,
and were grouped into 5 phyla, 16 genera, and 23 novel
phylotypes. In comparison, for 20 skin samples from 6 healthy
subjects, we previously detected 247 SLOTUs, which belonged in
10 phyla [11]. The numbers of species per skin sample was not
significantly different between the healthy subjects and those with
psoriasis (Figure 1, Panel B). One sample from a patient with
psoriasis yielded one sequence representing another phylum,
Planctomycetes, comprised of aquatic bacteria found in fresh and
marine water samples [26]. Overall, the bacteria detected from the
39 human skin specimens from this and the prior study comprise
366 different SLOTUs (Table 2, Figure 2 and Figure S1). Archaea
were not identified in any of the 39 samples from healthy persons
and patients with psoriasis.
Distribution at the phylum level
Firmicutes and Actinobacteria, the dominant phyla in samples of the
healthy and diseased skin, were found in each sample, representing
.80% of the clones (Table 3). The most abundant and diverse
phylum populating the psoriatic lesions was Firmicutes (46.2%),
significantly (P,0.001) overrepresented compared to the unin-
volved skin samples of the same patients (39.0%), as well as from
healthy persons (24.4%). In contrast, Actinobacteria, the most
prevalent and diverse phylum in the samples from normal skin
of both healthy persons (47.6%) and from the psoriasis patients
(47.8%), was significantly (P,0.01) lower (37.3%) in the psoriatic
lesions. Sequences representing the phylum Proteobacteria were
detected less frequently from psoriatic lesion samples (11.4%),
compared with samples from healthy persons (21.9%, P,0.001).
Distribution at the genus level
In total, 166 genera were detected in the 39 samples from
human skin, although 10 of the most common genera accounted
for the majority of clones from both the healthy and diseased skin
samples (Table S1). Only 20 genera were found in all 4 groups of
specimens (NNT1, NNT2, PN and PP), but none of the genera
was found in every sample. Corynebacterium, Staphylococcus, Strepto-
coccus, and Propionibacterium were the dominant genera in the
samples from normal skin, including healthy persons and patients
with psoriasis, as well as from the psoriatic lesions, accounting for
.50% of all clones. Clones representing the genus Streptococcus
were detected significantly more frequently (15.2610.4%) from
psoriatic lesion samples (P,0.001) than from the uninvolved skin
samples of the patients (3.462.5%). In contrast, Propionibacterium






e (n=13) PN+PP (n=19) All (n=39)
Number of clones 1,221 817 2,038 611 1,314 1,925 3,963
SLOTUs (S) 182 130 247 95 188 212 366
Singletons 67 46 91 38 73 77 125
Simpson’s index of diversity (1-D) 0.94 0.93 0.94 0.94 0.97
f 0.96 0.96
Shannon-Weaver(H) 4.04 3.68 4.13 3.53 4.21
g 4.18 4.40
Evenness(H/lnS) 0.78 0.76 0.75 0.78 0.80
h 0.78 0.75
Good’s estimator of coverage (%) 94.5 94.4 95.5 93.8 94.4 96.0 96.9
Chao1 246.1 161.1 328.2 135.1 276.8 292.1 476.0
Chao1 standard deviation 20.7 12.0 22.4 17.3 28.0 24.2 25.8
aNNT1: 12 samples from six healthy people, reported in a prior study (11)
bNNT2: Eight samples from four of the six healthy persons collected 8–10 months later (11)
cNN: All 20 samples from the six healthy persons (NNT1+NNT2).
dPN: Six samples from normal skin of six patients with psoriasis.
ePP: 13 samples from psoriatic lesions from six patients with psoriasis.
fP,0.001 compared with NN and PN.
gP,0.001 compared with PN, P=0.3 compared with NN.
hP,0.001 compared with NN, P=0.4 compared with PN.
doi:10.1371/journal.pone.0002719.t001
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from the healthy subjects and in the normal skin from psoriatic
patients (12.3621.6%), significantly higher than in the psoriatic
lesions (2.965.5%) (P,0.001). The most common genera detected
in the samples from normal and diseased skin were similar
(Figure 3), but the proportions differed (Panels A and B). The ratio
of Streptococcus to Propionibacterium (S/P ratio) in the 2,649 clones
from healthy persons and normal skin of patients with psoriasis
was 0.4. In contrast, the S/P ratio (5.0) in the 1,314 clones from
psoriatic lesion samples was significantly (P=0.01) higher.
Distribution at the SLOTU level
Table S2 lists the 366 SLOTUs represented in superficial
human skin, reflecting the prior [11] and the current study. The
most numerous species identified belonged to the genera
Corynebacterium, Staphylococcus, Streptococcus, and Anaerococcus. In total,
32 SLOTUs (8.7%) belonging to 15 genera were detected in all
four groups of specimens, accounting for 63.2% of all clones. The
four most prevalent bacterial species in each of the different skin
specimen groups, accounted for 29.6,44.0 % of all clones in that
group (Table S3). Propionibacterium acnes was the most prevalent
species in the samples from the healthy subjects
(Mean6SD:20.2616.0%) and from the unaffected skin of the
patients with psoriasis (Figure 3, Panel C). Representation of P.
acnes was much lower (2.665.1%) in the samples from the lesions
of the patients with psoriasis than in the samples from normal
persons (Figure 3, Panel D) (P,0.001); normal skin from psoriasis
patients showed intermediate levels (11.7620.4%). Staphylococcus
Figure 1. Diversity of bacterial species in 39 skin specimens from 12 subjects. Panel A. Collector’s curves of SLOTU richness of
pooled skin samples from six healthy subjects and six patients with psoriasis. Each curve reflects the observed (Sobs) or estimated (Chao1)
richness values obtained in 3 different groups of 16S rDNA clones. PP+PN indicates the 1,925 (1,314 from psoriatic lesion and 611 from uninvolved
skin, respectively), clones from six patients with psoriasis, added to the data set in an arbitrary order. NN includes 2,038 clones from healthy persons
reported in a prior study [11]. Overall, the sequences detected from the (Total) 39 human skin specimens from these studies represent 366 different
SLOTUs, whereas the Chao1 score estimates that the skin bacterial biota contains 476 SLOTUs. Based on this prediction, Good’s estimator of coverage
is 96.9%. Panel B. Diversity at the species level. The 20 samples from 6 healthy subjects (pink) and 19 samples from 6 patients with psoriasis
(blue) are indicated by the color designations. NNT1 (n=12) represents left and right forearm skin for six subjects, NNT2 (n=8) represents the
resampling of four subjects 8–10 months later [11]. PN (n=6) represents uninvolved skin from six patients with psoriasis. The samples from healthy
subjects and from uninvolved skin from psoriatic patients are indicated with solid symbols, and the samples from psoriatic lesions are indicated with
open symbols. All samples from the same subject are indicated by the same symbol. For each group, the horizontal line indicates the median of the
number of SLOTU.
doi:10.1371/journal.pone.0002719.g001
Table 2. Number of genera and SLOTU detected in 39 human skin samples
Category Normal subjects
a Psoriatic subjects All (n=39)
Time 1 (n=12) Time 2 (n=8) Normal skin (n=6) Lesions (n=13)
No. of samples 12 8 6 13 39
No. of clones 1,221 817 611 1,314 3,963
Total No. of genera 91 68 43 86 166
Genera/sample
b 19.066.6 17.865.5 11.864.6 17.866.9 17.366.6
Total No. of SLOTU 182 130 95 188 366
SLOTU/sample
b 30.869.1 28.568.4 23.767.8 29.267.9 28.768.4
Total No. of novel SLOTU 30 19 12 22 66
Novel SLOTU /sample
b 3.363.5 3.463.5 2.261.5 2.061.9 2.662.7
aFrom a prior study (11)
bMean6SD.
doi:10.1371/journal.pone.0002719.t002
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represented 1.1% and 2.8% of the clones from the unaffected and
diseased samples of the patients, respectively (Table S2). The
distribution of gram-positive and gram-negative anaerobic and
facultative bacterial species in psoriatic lesions in the six patients
differed from their own normal skin (Table S4). The major
differences were found in anaerobic bacterial species between the
two groups (P,0.05), with the most significant difference found for
Propionibacterium species (P,0.001).
Double principal coordinate analysis (DPCoA) of the
samples from human skin
Similarities in SLOTU distributions between skin samples were
evaluated using DPCoA (Figure 4). Four hypotheses concerning
the overall grouping of samples were tested. First, analysis using all
39 samples of human skin from 12 persons (6 healthy persons and
6 patients with psoriasis) showed that those samples from the same
subject were more similar to each other than to samples from other
subjects (P,0.001). The same result was found when only
analyzing the newly obtained 19 samples from the six patients
with psoriasis (P= 0.006). Second, in analysis of the 19 samples
from the patients with psoriasis, those obtained from psoriatic
lesions were not significantly different than those from unaffected
skin from the same patient, although these was an overall trend
(P=0.062). Third, the samples of psoriatic skin from the patients
(n=13) were clustered together, compared to samples of normal
skin from healthy subjects (n=20) (P=0.001). Fourth, the samples
obtained from unaffected skin from the patients with psoriasis
(n=6) were not significantly different from those from normal skin
of healthy subjects (n=20) (P=0.12).
The 16S rDNA clone library profiles from all 39 human skin
samples (Figure S1) also were compared using Unifrac analysis
(Figure S2); samples from the same person also often clustered
together, as did clinical group of specimens.
Discussion
The skin is a complex habitat with many residential bacterial
species. A sterile milieu prenatally, human skin becomes host to
resident bacteria soon after birth [27]. The normal microbiota acts
as a barrier against colonization of potentially pathogenic
introduced microbes and against overgrowth of already present
opportunistic microorganisms. Microbial metabolism also poten-
tially has both beneficial and harmful effects for the host [27,28].
Figure 2. Phylogenetic analysis of bacterial 16S rDNA detected in 39 samples from human skin. From 3,963 clones, sequences
representing 11 bacterial phyla and 366 SLOTUs were observed. The numbers in parentheses indicate the number of SLOTUs in each phylum.
Alignments were done with Greengenes, and misalignments were manually in MEGA 4.0 [38], evolutionary distances were calculated with the Jukes–
Cantor algorithm, and phylogenetic trees were determined by the Neighbor-Joining method; with 1,000 trees generated, bootstrap confidence levels
are shown at tree nodes for values $50%. Panel A: Phylogenetic analysis of 20 samples from 6 healthy subjects. Panel B: Phylogenetic analysis of 13
samples from the lesions of 6 patients with psoriasis.
doi:10.1371/journal.pone.0002719.g002
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largely unexplored.
We developed approaches to the assessment of the major
microbial populations in the human skin using molecular
techniques, based on ribosomal operons and PCR [11,12], and
we now apply this technique to understanding the microbiology of
skin involved with psoriasis. By adding more subjects and skin
locations to our studies, the number of bacterial species continued
to expand, with nearly 500 SLOTUs projected, and no plateau of
the collectors curve. These observations suggest that human skin is
a highly diverse ecosystem, with levels of bacterial diversity
perhaps approaching that of the colon [4].
We sought to determine whether the involved skin from subjects
with psoriasis differed in colonization patterns compared with their
own uninvolved skin, and with skin from healthy persons.
Although there were general similarities in the types of bacteria
present and in general proportions, important differences
emerged. First, the overall ecological diversity of the microbial
population overlaying the lesions was greater than for other skin
samples (Table 1). This may reflect the heterogeneity of the types
of lesions sampled, compared with the relatively homogeneous
uninvolved skin. Second, there were significant differences in the
distribution of Actinobacteria, Proteobacteria, and Firmicutes, the three
major phyla populating normal skin, with the former two phyla
underrepresented, and the latter overrepresented, as well as
significant differences for minor phylum Bacteroidetes. Although
these represent the aggregation of numerous genera and species,
the significant differences suggest that there has been substantial
ecological disturbance, in contrast to the observations for fungal
species in relation to psoriasis [12]. Third, there was a striking and
progressive underrepresentation of the genus Propionibacterium, and
its major human species P. acnes, as the samples from healthy
persons, healthy skin from psoriasis patients, and psoriatic lesions
were compared (Table S3, Figure 3). The use of the same PCR
primers for all groups of specimens suggest that differences in
amplification efficiencies that occur when different primer pairs
are used can not explain the observations.
Propionibacterium, and P. acnes in particular, are dominant
organisms in normal skin [29], as shown in culture-based studies
[10], and in our molecular analyses [11]. A diminution in these
numbers could be a reflection of the disordered ecological niches
that are inhospitable to these organisms, could play a role in the
pathogenesis of the disease, or could represent the effects of
various treatments of psoriasis. The lack of any treatment of the
subjects in this study, and that their unaffected skin showed an
intermediate diminution provides evidence against any effect of
treatments, but suggests that ecological disordering could be
occurring, although at a subclinical level. Alternatively, the
presence P. acnes has some protective role. One possible
explanation is that P. acnes has immunomodulatory constituents
[30] that could be playing a role in signaling human cells [31].
Lastly, P. acnes may be displaced by more aggressive organisms or
conversely, might protect the skin against more aggressive
microbes, and its diminution reduces that barrier. In one scenario,
P. acnes levels are affected by other phenomena; in the other, it
plays a causative role. Favoring these microbial competition
hypotheses is the greater representation of streptococcal and
staphylococcal species in the psoriatic lesions, however, Group A
Streptococcus pyogenes and Staphylococcus aureus were absent or
minimally present.
Future studies must involve more quantitative techniques to
determine whether the relative representations that we observe
reflect absolute differences or not. Clearly, examination of greater
numbers of lesions, with different clinical and pathological
phenotypes, will provide more accurate stratification of the
microbial associations. Even if the diminished representation of
Propionibacterium is merely a secondary marker of the psoriatic
process, understanding its presence could aid in the diagnosis and
Table 3. Phyla detected in skin samples









Actinobacteria 51.6619.8 41.6617.2 47.6 619.0 47.8639.2 37.3626.1
c
Firmicutes 23.7611.2 25.3619.2 24.4614.5 39.0632.8 46.2621.6
d
Proteobacteria 19.3617.5 25.8620.0 21.9618.3 10.1616.7 11.4611.5
e
Bacteroidetes 1.562.4 3.663.2 2.462.9 2.967.2 4.567.6
Cyanobacteria 0.260.6 0.561.1 0.360.8 0.260.4 0
Fusobacteria 0 0.160.4 0.160.2 0 0.260.4
Planctomycetes 00 00 0 . 1 60.3
TM7 0 0.761.4 0.360.9 0 0.260.8
Deinococcus-Thermus 2.866.6 2.264.2 2.665.6 0 0
Thermomicrobia 0.160.3 0 0.160.2 0 0
Unclassified 0.761.7 0.160.4 0.561.3 0 0
aFrom a prior study (11)
bNumber of clones studied.
cP,0.001 compared with NN, and ,0.001 compared with normal skin.
dP,0.001 compared with NN, and 0.003 compared with normal skin.
eP,0.001 compared with NN, and 0.37 compared with normal skin.
doi:10.1371/journal.pone.0002719.t003
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differences at the P. acnes strain level, but such also could be
relevant in future examinations.
Finally, this work raises the possibility that knowledge of specific
components of the microbiota in disease could lead to attempts to
reduce numbers of over-represented organisms, and to increase
populations of commonly occurring resident microbes that are
diminished in disease. Such a probiotic (or a prebiotic) approach
will require much greater knowledge of the specific characteristics
of key human microbial constituents, and determinations of
microbial genotypes and phenotypes in relation to disease.
Materials and Methods
Clinical specimens
This study was approved by the NYU Institutional Review
Board and all subjects provided written informed consent. Six
patients with psoriasis were analyzed. From each patient, at least 3
skin samples, including one sample from unaffected skin and at
least two samples from psoriatic lesions, were studied. Subjects
included three men and three women; details of their demographic
and clinical characteristics are shown in Table S5. None of the
patients were currently receiving therapy, either topical, ultravi-
olet, or systemic, for psoriasis.
Specimen processing
Methods for sampling superficial skin have been described [11].
Lesions differing in the extent of erythema, swelling, and scaling,
as well as normal skin were sampled by swabbing the skin with a
cotton pledget that had been soaked in sterile 0.15M NaCl with
0.1% Tween-20 (Fisher Scientific, Fair Lawn, NJ). DNA was
extracted from the swabs in a PCR-free clean-room by using the
DNeasy Tissue Kit (Qiagen, Chatsworth, CA); since Gram-
positive bacteria are more resistant to lysis than Gram-negative
Figure 3. The most common bacterial genera (Panels A, B) and bacterial (Panels C, D) species found in human skin, based on 16S
rDNA clones. Panel A. Samples from healthy persons (n=20) and normal skin (n=6) of patients with psoriasis (n=2,649 clones). The ratio of
Streptococcus to Propionibacterium is 0.4. For the four most common genera, the percentage of clones is shown. Panel B. Samples from the lesions
(n=13) of patients with psoriasis (n=1,314 clones). The ratio of Streptococcus to Propionibacterium is 5.0 Panel C. Samples from healthy persons
(n=20) and normal skin (n=6) of patients with psoriasis (n=2,649 clones). The ratio of Streptococcus mitis to Propionibacterium acnes is 0.2. Panel D.
Samples from the lesions (n=13) of patients with psoriasis (n=1,314 clones). The ratio of Streptococcus mitis to Propionibacterium acnes is 2.5. Code:
Propionibacterium acnes (A1, B7); Corynebacterium tuberculostearicum (A2, B1); Staphylococcus hominis (A5, B2); Streptococcus mitis (A4, B3);
Staphylococcus epidermidis (A8, B9); Enhydrobacter aerosaccus (A3); Staphylococcus capitis (A6); Staphylococcus caprae (A7); Dermacoccus AF409025
(A9); Corynebacterium mucifaciens (A10); Corynebacterium simulans (B4); Rothia mucilaginosa (B5); Staphylococcus aureus (B6); Streptococcus
salivarius (B8); Flavobacteriaceae DQ337018 (B10).
doi:10.1371/journal.pone.0002719.g003
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isolation from Gram-positive bacteria was followed. Samples were
eluted in 100 ml AE buffer, and to eliminate bacterial or DNA
contamination, the enzymatic lysis buffer was passed through a
micro-centrifuge filter (MW threshold 30,000 Daltons, Amicon,
Bedford, MA) at 7476g for 20 min.
16S rDNA PCR amplification
Two different primer sets were used for PCR: one set (8F: 59-
AGA GTT TGA TYM TGG CTC AG and 1510R: 59-TAC
GGY TAC CTT GTT ACG ACT T) was specific to the 16S
rRNA gene of bacteria, which amplifies ,1.5 kb PCR products,
based on positions 8 to 1513 of the E. coli 16S rRNA gene
[8,32,33]. To each 5 ml of the suspension of extracted template
DNA was added 45 ml of a PCR mixture containing 5 ml of 10x
PCR buffer (Qiagen), 2.5 mM MgCl2, 200 mM each dNTP,
20pmol of each primer, and 1.25units of TaqDNA polymerase.
PCR was performed for 2 min at 94uC, followed by 30
amplification cycles of 45 s at 94uC, 30 s at 52uC, and 90 s at
72uC, with a final cycle for 20 min at 72uC. The second primer set
[Arch21F: 59-TTC CGG TTG ATC CYG CCG GA-39 [34], and
A19R: 59-YCC GGC GTT GAM TCC AAT T-39 [7]] was
specific to archaea. PCR was carried out in a 50 ml reaction
containing 16PCR buffer, 2 mM MgCl2, 200 mM each dNTP,
10pmol of each primer, 1.25units of TaqDNA polymerase and
5 ml of DNA template. The amplification procedure comprised of
one cycle for 4 min at 95uC followed by 35 cycles of 30 s at 95uC,
1 min at 55uC and 1 min at 72uC, and one cycle of 5 min at 72uC.
The results of PCR amplifications were examined by electropho-
resis on 1% agarose gels.
16S rDNA clone libraries
The PCR products were separated from free PCR primers using
a PCR purification kit (Qiagen), ligated with the pGEM-T-Easy
vector (Promega, Madison, WI), and used to transform E. coli
DH5a competent cells. Putatively positive clones were screened by
PCR with Sp6/T7 primers. The cloned inserts underwent
sequence analysis using PCR primers 8F and 27R (reverse primer
59-CGA CAI CCA TGC AIC ACC T, corresponding to position
8 to 1064 of the E. coli 16S rRNA). Each sequence was manually
edited in conjunction with its chromatogram with Sequencher,
adjusting for quality. DNA sequences of approximately 980 bases
were obtained initially to determine either identity or approximate
phylogenetic position. For those clones containing inserts of
ambiguous phylogenetic status, nearly full-length 16S bacterial
rRNA sequences (,1,500 bp) were obtained, using the additional
Figure 4. DPCoA of SLOTU relatedness in 39 human skin samples obtained from healthy subjects and psoriatic patients. The healthy
subjects were designated A–F, and at each sampling both left (L) and right (R) forearm skin was examined. In four subjects, new specimens were
obtained 8–10 months later (e.g. designated AL2). The psoriatic patients were designated 1, 2, 3, 4, 6, and 8, PN indicates that sample is from
uninvolved skin and PP is from psoriatic lesions. In a representation of the first two orthogonal principal axes, based on a sample dissimilarity matrix,
samples from the same subjects at the same time point are plotted by using the same color, and the normal skin and psoriatic lesion samples are
indicated by thin and thick circle walls, respectively. The size of each circle is proportional to the sample’s Rao diversity index. The scale (bottom right)
indicates the relative diversity of the populations within the circles, with the test sample of smallest diversity (2PN) indexed as 1.0.
doi:10.1371/journal.pone.0002719.g004
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determined sequences were compared to those available in the
RDP II (release 9.39) [35] and GenBank (www.ncbi.nlm.gov)
databases, using the standard nucleotide-nucleotide BLAST
program to ascertain their closest relatives. A novel phylotype
was defined as a sequence that differed from the closest GenBank
entry by .2%. Data for the novel sequences were submitted to
GenBank (GenBank accession numbers: EF419345-EF419425).
Phylogenetic analyses
DNA sequences of 940 to 1450 bp were obtained for about 100
clones from each sample, for a total of 1,933 clones. All sequences
were examined for chimerism by using Chimera Detection at
RDP II (release 8.1) and Bellerophon [36]. In total, 8 clones were
removed from the phylogenetic analysis. The remaining 1,925
sequences were compared with those of RDP II (release 9.39) [35]
and in GenBank to identify SLOTUs (species-level operational
taxonomic units), as reported [8]. The sequences were aligned
with NAST at Greengenes (http://greengenes.lbl.gov/cgi-bin/
nph-index.cgi) [37] Misalignments were manually curated in
MEGA 4.0 [38], and then hypervariable regions were masked by
using MASK COLUMNS at Greengenes [37]. The phylogenetic
trees were generated using MEGA 4.0 [38]. Evolutionary
distances were calculated with the Jukes-Cantor algorithm [39].
The statistical strength of the Neighbor-Joining method was
assessed by bootstrap resampling (1,000 replicates) [40].
Statistical analyses
Double Principal Coordinate Analysis (DPCoA) [41] was used to
evaluate sample diversity and the relationships amongst samples.
This method uses phylotype differences to derive the dissimilarity
matrix of samples and to calculate the sample diversity. In this
analysis, the dissimilarities between different phylotypes are
calculated based on the sum of distances to the common ancestor
of two phylotypes on the phylotype tree. To facilitate the
visualization of sample dissimilarity and diversity, the first two
orthogonal principal axes were obtained based on the sample
dissimilarity, and were plotted to show the distribution of samples in
a two-dimensional space. The diversity information can be
decomposed into within- and between- sample diversity values.
Thisallowed the use of a ‘‘pseudoF’’[4]statistic (the ratio of within-
cluster diversity and between-cluster diversity) to examine possible
clustering phenomena, and significance was evaluated by permu-
tation tests. Results from 2,038 sequences from healthy persons, as
reported [11], were included for comparison of the microbiota
between unaffected skin and psoriatic lesions. UniFrac [42] also was
used to assess for significant differences between samples.
Supporting Information
Table S1 The 10 most common genera found in human skin
Found at: doi:10.1371/journal.pone.0002719.s001 (0.05 MB
DOC)
Table S2 Representation of 366 bacterial SLOTUs in the
human skin
Found at: doi:10.1371/journal.pone.0002719.s002 (0.84 MB
DOC)
Table S3 The four most common species found in different
groups of skin specimens
Found at: doi:10.1371/journal.pone.0002719.s003 (0.04 MB
DOC)
Table S4 Supplemental information
Found at: doi:10.1371/journal.pone.0002719.s004 (0.03 MB
DOC)
Table S5 Origin of skin samples
Found at: doi:10.1371/journal.pone.0002719.s005 (0.10 MB
DOC)
Figure S1 Phylogenetic analysis of bacterial 16S rDNA detected
in 39 samples from human skin of 12 persons. From 3,963 clones,
sequences representing 11 bacterial phyla and 366 SLOTUs were
observed. The numbers in parentheses indicate the number of
SLOTUs in each phylum. Alignments were done with Green-
genes, and misalignments were manually in MEGA 4.0 (38),
evolutionary distances were calculated with the Jukes-Cantor
algorithm, and phylogenetic trees were determined by the
Neighbor-Joining method; with 1,000 trees generated, bootstrap
confidence levels are shown at tree nodes for values $50%.
Found at: doi:10.1371/journal.pone.0002719.s006 (0.78 MB TIF)
Figure S2 Hierarchical clustering of 39 human skin samples
from healthy and psoriasis subjects using weighted Unifrac. The
numerical support for nodes present in $50% of sequence
jackknifing is indicated, based on 1,000 permutations. The healthy
subjects were designated A–F, and at each sampling both left (L)
and right (R) forearm skin was examined. In four subjects, new
specimens were obtained 8–10 months later (e.g. designated AL2).
The psoriatic patients were designated 1, 2, 3, 4, 6, and 8, PN
indicates that sample is from uninvolved skin and PP is from
psoriatic lesions. The highly significant clustering observed relates
to samples from the same person.
Found at: doi:10.1371/journal.pone.0002719.s007 (1.11 MB TIF)
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